About: Ferrocene-Mediated Proton-Coupled Electron Transfer in a Series of Ferrocifen-Type Breast-Cancer Drug Candidates

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Ferrocene-Mediated Proton-Coupled Electron Transfer in a Series of Ferrocifen-Type Breast-Cancer Drug Candidates Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scholarly article by Elizabeth A. Hillard et al published January 2006 in Angewandte Chemie International Edition

Attributes	Values
rdf:type	Item
description	artículu científicu (ast) wetenschappelijk artikel (nl) article scientifique publié en 2006 (fr) наукова стаття, опублікована в січні 2006 (uk) im Jahr 2006 veröffentlichter wissenschaftlicher Artikel (de) scholarly article by Elizabeth A. Hillard et al published January 2006 in Angewandte Chemie International Edition (en)
publication date	wds:Q57391698-66C5C141-EC1D-4EC1-9643-54669567A58F
publication date	2006-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57391698-9676DABE-FE2F-4CB3-AEE8-EB6CE85FB133
language of work or name	English
cites work	wds:Q57391698-3212211B-7EB8-4022-864D-B66D28C97886
cites work	The first organometallic selective estrogen receptor modulators (SERMs) and their relevance to breast cancer
author name string	wds:Q57391698-E632E0C9-6915-45BA-9FF6-AE037139B8E9
author name string	Anne Vessières
rdfs:label	Ferrocene-Mediated Proton-Coupled Electron Transfer in a Series of Ferrocifen-Type Breast-Cancer Drug Candidates (en) Ferrocene-Mediated Proton-Coupled Electron Transfer in a Series of Ferrocifen-Type Breast-Cancer Drug Candidates (nl)
skos:prefLabel	Ferrocene-Mediated Proton-Coupled Electron Transfer in a Series of Ferrocifen-Type Breast-Cancer Drug Candidates (en) Ferrocene-Mediated Proton-Coupled Electron Transfer in a Series of Ferrocifen-Type Breast-Cancer Drug Candidates (nl)
name	Ferrocene-Mediated Proton-Coupled Electron Transfer in a Series of Ferrocifen-Type Breast-Cancer Drug Candidates (en) Ferrocene-Mediated Proton-Coupled Electron Transfer in a Series of Ferrocifen-Type Breast-Cancer Drug Candidates (nl)
author	wds:Q57391698-0338EECC-6FC1-45B8-8F75-5BEAEB9B1070 wds:Q57391698-173B159A-8123-456A-A1DF-5554689F2ADD wds:Q57391698-2A2BBC81-019B-4AD3-AAB8-4F4269A6AC5B wds:Q57391698-D831D0A7-6885-47F8-9537-D84DDAD2DC1D
author	Christian Amatore Gérard Jaouen Elizabeth A. Hillard Laurent Thouin
title	wds:Q57391698-397944C2-0CA8-43C6-8BF7-B3B406C8772C
title	Ferrocene-Mediated Proton-Coupled Electron Transfer in a Series of Ferrocifen-Type Breast-Cancer Drug Candidates (en)
page(s)	wds:Q57391698-9AA5C1AA-5C52-4711-B419-65AB3C2C2ABC
page(s)	285-290
instance of	wds:Q57391698-57B232BD-821A-4ADD-B8F6-121871D48FF8
instance of	scholarly article
main subject	wds:Q57391698-19E238AF-FFDB-46B9-A589-27C17DF9F055 wds:Q57391698-B56BBD78-A9CF-4DF0-A0FA-987EC55EF058
main subject	general chemistry catalysis
PubMed ID	wds:Q57391698-25410E5A-A42C-4473-AF64-C830AC7167CD
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16312004
PubMed ID	16312004
published in	wds:Q57391698-1CAC99BC-1370-4E95-A068-63342F8CFB26
published in	Angewandte Chemie International Edition
issue	wds:Q57391698-BFE60D48-E57A-439E-BF31-9C4E000B7B9E
volume	wds:Q57391698-7C8A1F49-B5CB-436D-9754-51519FDE4D67
issue	2
volume	45
DOI	wds:Q57391698-5D4D2C24-CE60-4573-98A9-2A4C81C4C9C0
DOI	http://dx.doi.org/10.1002/ANIE.200502925
DOI	10.1002/ANIE.200502925
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57391698
is cites work of	Similar Biological Activities of Two Isostructural Ruthenium and Osmium Complexes Organometallic anticancer compounds Cytotoxic and antioxidant properties of active principals isolated from water hyacinth against four cancer cells lines Redox activation of metal-based prodrugs as a strategy for drug delivery New trends for metal complexes with anticancer activity Ferrocenyl catechols: synthesis, oxidation chemistry and anti-proliferative effects on MDA-MB-231 breast cancer cells. Bis-arylidene oxindoles as anti-breast-cancer agents acting via the estrogen receptor Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs. Bioorganometallic chemistry--from teaching paradigms to medicinal applications Ferrocifen type anti cancer drugs Nanotherapeutic systems for local treatment of brain tumors Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft. Acylated mono-, bis- and tris- cinchona-based amines containing ferrocene or organic residues: synthesis, structure and in vitro antitumor activity on selected human cancer cell lines Controlling Platinum, Ruthenium and Osmium Reactivity for Anticancer Drug Design. Synthesis and antiproliferative activity of hydroxyferrocifen hybrids against triple-negative breast cancer cells Efficient new constructs against triple negative breast cancer cells: synthesis and preliminary biological study of ferrocifen-SAHA hybrids and related species. Synthesis, cytotoxicity, and COMPARE analysis of ferrocene and [3]ferrocenophane tetrasubstituted olefin derivatives against human cancer cells Ferrocenyl quinone methides as strong antiproliferative agents: formation by metabolic and chemical oxidation of ferrocenyl phenols. Nucleoside analogues with a 1,3-diene-Fe(CO)3 substructure: stereoselective synthesis, configurational assignment, and apoptosis-inducing activity. Cytotoxicity of Pyrazine-Based Cyclometalated (C^Npz^C)Au(III) Carbene Complexes: Impact of the Nature of the Ancillary Ligand on the Biological Properties Solid-phase synthesis, characterization, and antibacterial activities of metallocene-peptide bioconjugates. ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage. Vesicular disruption of lysosomal targeting organometallic polyarginine bioconjugates Synthesis and biological evaluation of chromium bioorganometallics based on the antibiotic platensimycin lead structure Structural and biological investigation of ferrocene-substituted 3-methylidene-1,3-dihydro-2H-indol-2-ones The presence of a ferrocenyl unit on an estrogenic molecule is not always sufficient to generate in vitro cytotoxicity. The ferroquine antimalarial conundrum: redox activation and reinvasion inhibition Palladacycles of sulfated and selenated Schiff bases of ferrocene-carboxaldehyde as catalysts for O-arylation and Suzuki-Miyaura coupling. Oxidative metabolism of ferrocene analogues of tamoxifen: characterization and antiproliferative activities of the metabolites. Deciphering the activation sequence of ferrociphenol anticancer drug candidates. Quantitative analyses of ROS and RNS production in breast cancer cell lines incubated with ferrocifens. Remarkable anticancer activity of ferrocenyl-terpyridine platinum(ii) complexes in visible light with low dark toxicity. The contrasting chemical reactivity of potent isoelectronic iminopyridine and azopyridine osmium(ii) arene anticancer complexes Antiparasitic and immunomodulatory activities of 1,1-bis(4-hydroxyphenyl)-2-phenyl-but-1-ene and its protected and free 2-ferrocenyl derivatives Understanding the interactions of diruthenium anticancer agents with amino acids Ferrocene-Decorated Phenol Derivatives by Trapping ortho -Quinone Methide Intermediates with Ferrocene Tamoxifen-like metallocifens target the thioredoxin system determining mitochondrial impairment leading to apoptosis in Jurkat cells. Anti-inflammatory AreneChromium Complexes Acting as Specific Inhibitors of NOD2 Signalling Metallocenes as Target Specific Drugs for Cancer Treatment Osmium carbonyl clusters: a new class of apoptosis inducing agents. Ferrocenyl Quinone Methide-Thiol Adducts as New Antiproliferative Agents: Synthesis, Metabolic Formation from Ferrociphenols, and Oxidative Transformation Synthesis and structure analysis of ferrocene-containing pseudopeptides. 1H-1,2,3-triazole-tethered uracil-ferrocene and uracil-ferrocenylchalcone conjugates: Synthesis and antitubercular evaluation. A series of unconjugated ferrocenyl phenols: prospects as anticancer agents Antimicrobial activity of organometallic isonicotinyl and pyrazinyl ferrocenyl-derived complexes Heterometallic platinum(II) compounds with β-aminoethylferrocenes: synthesis, electrochemical behaviour and anticancer activity Antioxidative activity of ferrocenes bearing 2,6-di-tert-butylphenol moieties Molecular mechanism of action of 2-ferrocenyl-1,1-diphenylbut-1-ene on HL-60 leukemia cells.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software